Monday, 26 October 2026
- FIVE AT FIVE: Anthropic files for the record books, London holds its nerve and Computacenter beats forecasts
That's your five for Monday
- Anthropic files for Nasdaq listing as first-half revenue hits $16.3bn
Anthropic has publicly filed to list on the Nasdaq, disclosing revenue of $16.3bn for the first half of 2026.
- Anthropic reportedly se to file publicly for IPO today as record debut nears
Anthropic plans to file publicly for an initial public offering today at around 9am in New York (2pm UK), according to Bloomberg, which cited people familiar…
- Flutter on track to meet US guidance as lower promotional spending eases miss fears, says Jefferies
Jefferies analysts say Flutter Entertainment's US business is tracking in line with third-quarter guidance, after earlier estimates had pointed to a miss.
- Shore Capital tells investors not to panic over UK retail as consumer confidence tumbles
Shore Capital has told investors not to hit the panic button on UK retail, despite a sharp slump in consumer confidence.
- FTSE 100 LIVE: London opens higher after as Computacenter sets the pace Update
The FTSE 100 rose 56 points, or about half a per cent, to 10,746 in early trading as oil prices eased from a six-month high.
- Is Currys a takeover target as European electricals retailers consolidate?
Analysts at RBC Capital Markets see scope for further consolidation among European consumer tech retailers, and have reiterated an "outperform" rating on…
- Panthera Resources sets December hearing for $1.58bn arbitration claim against India
Panthera Resources, the gold explorer with assets in West Africa and India, said the written phase of its arbitration against India is complete, with a hearing…
- Safestay warns of liquidity pressure as trading stays below expectations
Safestay, the hostel operator, said year-to-date trading remains below the board's original expectations and that its liquidity is under pressure over the…
- GSK rectal cancer drug clears tumours in 76% of patients without surgery or chemotherapy
GSK, the FTSE 100 drugmaker, said its immunotherapy Jemperli (dostarlimab) produced a complete response in 76% of patients with a genetically defined form of…
- Hutchmed lung cancer combination cuts risk of death by 32% in phase III trial
Hutchmed, the Hong Kong-based cancer drug developer, said its drug Orpathys (savolitinib) combined with AstraZeneca's Tagrisso (osimertinib) cut the risk of…
- Computacenter raises profit outlook as record order backlog hits £12.6bn
Computacenter, the FTSE 100 technology services provider, has raised its full-year profit guidance after a third quarter that beat its own expectations.
- Plus500 raises full-year guidance after strong third quarter
Plus500, the FTSE 250 online trading group, expects full-year revenue and earnings to beat market forecasts after a third quarter in which new customer numbers…
- Man Group expands Meiji Yasuda partnership with $1.25bn private credit pledge
Man Group, the alternative investment manager, said Japanese insurer Meiji Yasuda intends to raise its capital commitment to Man's strategies to 200 billion…
- FTSE 100 LIVE: London set top open higher after a mixed session in Asia Update
It's Budget week here in the UK, so expect the drip-drip of speculation as we head towards Wednesday.
- FTSE 100 LIVE: Asian markets mixed as oil retreats from recent highs
Asian sharemarkets were mixed on Monday as investors weighed easing oil prices against continuing Middle East tensions, a weak Wall Street lead and a busy week…